Expectedly, our data showed that overexpression of RRM2 promoted the proliferation, inhibited the apoptosis, and increased the chemotherapy resistance of NSCLC cells through upregulating EGFR expression and AKT phosphorylation. This evidence concerns the gene EGFR and non-small cell lung carcinoma.